Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Non-Small-Cell Lung 2Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer 1Neoplasms, Squamous Cell 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphoma 1Hodgkin Disease 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1

Interventions

Nivolumab 3Gemcitabine 3pembrolizumab 2vandetanib 1temsirolimus 1sargramostim 1motexafin gadolinium 1motesanib diphosphate 1durvalumab 1cc-486 1carboxyamido-triazole 1belinostat 1atezolizumab 1advexin 1Watchful Waiting 1Vorinostat 1Topotecan 1TTI-621 1Specimen Handling 1Rituximab 1Ritonavir 1Radiotherapy 1RXDX-106 1Polymerase Chain Reaction 1Paclitaxel 1Nicotine 1Microarray Analysis 1Metformin 1Magnetic Resonance Spectroscopy 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Injections, Subcutaneous × Thoracic × Clear all
NCT02376699 2023-05-01

Safety Study of SEA-CD40 in Cancer Patients

Seagen Inc.

Phase 1 Terminated
159 enrolled
DermatologicHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡